Eikon Therapeutics, Inc.

SV Health Investors announced the final closing for its second Dementia Discovery Fund, DDF-2, with $269m in commitments from investors and non-profit organizations willing to put their money behind s

Biopharma financing during the first quarter of 2025 totaled $13.1bn from 206 deals. The venture financing category made up the greatest proportion of both the aggregate Q1 financing dollars (46%) and

Venture capital financing for biopharmaceutical companies may be headed into another downturn, reversing a surge in start-up funding that occurred in 2024. New data from Evaluate show that only 109 dr

Included for 2025 are investors, CEOs of small and mid-sized companies, rising employees in larger businesses, and individuals spearheading unique health initiatives worldwide. The 30 individuals list